🚀 VC round data is live in beta, check it out!

Dedicare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dedicare and similar public comparables like Administer, Ogunsen, eSense Human Resources, DLSI and more.

Dedicare Overview

About Dedicare

Dedicare AB is engaged in the business of hiring and recruiting doctors, nurses, medical secretaries and other staff in health care. The company also recruits social workers, social scientists, psychologists and other personnel in the industry of social work.


Founded

1995

HQ

Sweden

Employees

1.2K

Financials (FY)

Revenue: $155M
EBITDA: $7M

EV

$31M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dedicare Financials

Dedicare reported last fiscal year revenue of $155M and EBITDA of $7M.

In the same fiscal year, Dedicare generated $23M in gross profit, $7M in EBITDA, and $4M in net income.


Dedicare P&L

In the most recent fiscal year, Dedicare reported revenue of $155M and EBITDA of $7M.

Dedicare expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Dedicare forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$155MXXXXXXXXX
Gross ProfitXXX$23MXXXXXXXXX
Gross MarginXXX15%XXXXXXXXX
EBITDAXXX$7MXXXXXXXXX
EBITDA MarginXXX4%XXXXXXXXX
EBIT MarginXXX3%XXXXXXXXX
Net ProfitXXX$4MXXXXXXXXX
Net MarginXXX2%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Dedicare Stock Performance

Dedicare has current market cap of $40M, and enterprise value of $31M.

Market Cap Evolution


Dedicare's stock price is $4.22.

See Dedicare trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$31M$40M-1.3%XXXXXXXXX$0.37

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dedicare Valuation Multiples

Dedicare trades at 0.2x EV/Revenue multiple, and 4.6x EV/EBITDA.

See valuation multiples for Dedicare and 15K+ public comps

Dedicare Financial Valuation Multiples

As of March 21, 2026, Dedicare has market cap of $40M and EV of $31M.

Equity research analysts estimate Dedicare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Dedicare has a P/E ratio of 11.5x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$40MXXX$40MXXXXXXXXX
EV (current)$31MXXX$31MXXXXXXXXX
EV/RevenueXXX0.2xXXXXXXXXX
EV/EBITDAXXX4.6xXXXXXXXXX
EV/EBITXXX7.0xXXXXXXXXX
EV/Gross ProfitXXX1.3xXXXXXXXXX
P/EXXX11.5xXXXXXXXXX
EV/FCFXXX4.5xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dedicare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dedicare Margins & Growth Rates

Dedicare's revenue in the last fiscal year declined by (15%).

See operational valuation multiples for Dedicare and other 15K+ public comps

Dedicare Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX(15%)XXXXXXXXX
EBITDA MarginXXX4%XXXXXXXXX
EBITDA GrowthXXX(30%)XXXXXXXXX
Opex to RevenueXXX12%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dedicare Public Comps

See public comps and valuation multiples for other Recruitment & Staffing comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
AdministerXXXXXXXXXXXXXXXXXX
OgunsenXXXXXXXXXXXXXXXXXX
eSense Human ResourcesXXXXXXXXXXXXXXXXXX
DLSIXXXXXXXXXXXXXXXXXX
GattacaXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Dedicare M&A Activity

Dedicare acquired XXX companies to date.

Last acquisition by Dedicare was on XXXXXXXX, XXXXX. Dedicare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Dedicare

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Dedicare Investment Activity

Dedicare invested in XXX companies to date.

Dedicare made its latest investment on XXXXXXXX, XXXXX. Dedicare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Dedicare

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dedicare

When was Dedicare founded?Dedicare was founded in 1995.
Where is Dedicare headquartered?Dedicare is headquartered in Sweden.
How many employees does Dedicare have?As of today, Dedicare has over 1K employees.
Who is the CEO of Dedicare?Dedicare's CEO is Bard Kristiansen.
Is Dedicare publicly listed?Yes, Dedicare is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Dedicare?Dedicare trades under DEDI ticker.
When did Dedicare go public?Dedicare went public in 2011.
Who are competitors of Dedicare?Dedicare main competitors are Administer, Ogunsen, eSense Human Resources, DLSI.
What is the current market cap of Dedicare?Dedicare's current market cap is $40M.
What is the current revenue of Dedicare?Dedicare's last fiscal year revenue is $155M.
What is the current EV/Revenue multiple of Dedicare?Current revenue multiple of Dedicare is 0.2x.
Is Dedicare profitable?No, Dedicare is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial